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In response to #COVID19, healthcare professionals should scale up virtual consultations for assessing 
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Editorial
Impact of COVID-19 shielding 
on physical activity and quality 
of life in patients with COPD
COVID-19 is a highly infectious disease that can 
cause severe respiratory illness, particularly in 
patients with pre-existing lung conditions such as 
COPD [1]. To prevent infection during the peak of 
the pandemic, patients considered to be clinically 
extremely vulnerable were instructed to “shield” at 
home, resulting in significant restrictions to usual 
daily activities and social interaction. In the absence 
of a preventative vaccine, these public health 
measures are imperative to reduce transmission 
of the virus. However, despite this positive aspect, 
there are likely to be harmful repercussions on 
people’s physical and mental health.
The adverse effects of physical inactivity in COPD 
patients are well known and include worsening of 
health-related quality of life (HRQoL) [2], along 
with an increased risk of hospitalisations and 
mortality [3]. The COVID-19 restrictions have posed 
challenges for the entire population to stay active, 
with many turning to online resources for support 
and guidance. However, some patients with limited 
access or knowledge of how to use these resources 
may be disadvantaged and might not benefit. In 
addition to the instruction to shield, the provision 
of many respiratory clinical services including 
pulmonary rehabilitation (PR) were suspended 
and staff redeployed. These programmes remain 
imperative for those with chronic lung disease, and 
the demand is now accompanied by an emerging call 
for rehabilitation/recovery programmes for COVID-
19 patients [4]. A wealth of evidence highlights the 
use of PR for improving exercise capacity, HRQoL 
and symptoms. PR also promotes adherence 
to health enhancing behaviours, facilitating the 
translation of enhanced exercise capacity to greater 
participation in physical activities  [5]. However, 
upon completion, these benefits tend to diminish 
over the first 6–12 months if no on-going exercise 
is performed [6]. The COVID-19 shielding period 
could, therefore, have potentially exacerbated the 
loss of health benefits attained by patients recently 
completing a PR programme. Studies employing 
maintenance interventions in the form of supervised 
and technology assisted exercise have shown some 
promise in maintaining PR benefits [7].
We followed up a cohort of 10 COPD patients 
(mean±sd forced expiratory volume in 1 s (FEV1): 
55±23% predicted), who completed an 8-week 
PR course between January and March 2020 in 
the North East of England. Physical activity was 
measured using accelerometry (Actigraph wGT3X; 
Actigraph, Pensacola, FL, USA) and the Clinical Visit 
of Proactive Physical Activity in COPD (C-PPAC) 
instrument [8] in the week preceding PR, the 
week following completion of PR and for a week 
3 months following completion of PR during the 
shielding period (April to July 2020). In addition, 
assessment of HRQoL (COPD Assessment Test 
(CAT) and Clinical COPD Questionnaire (CCQ)) 
and psychological wellbeing (Hospital Anxiety 
and Depression Scale (HADS)) was undertaken. 
Patients were first contacted by telephone, then 
an accelerometer and the questionnaires were 
sent to them in the post. These patients had 
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been previously enrolled in a study (ClinicalTrials.
gov identifier: NCT03749655) investigating the 
inclusion of physical activity promotion alongside 
PR and were therefore familiar with the assessment 
procedures and willing to be monitored.
The results showed a significant and clinically 
meaningful (>600–1100 steps per day [9]) decrease 
in daily steps from post-PR to shielding, as well as 
pre-PR to shielding (figure 1a). The deterioration in 
daily steps was also accompanied by a significant 
and clinically meaningful (4 points [8]) worsening 
in the C-PPAC score from post-PR to shielding 
(figure 1b), demonstrating not only a reduction 
in the amount of activity undertaken, but also an 
increase in the perceived difficulty of conducting 
physical activity.
A previous multicentre trial involving 157 COPD 
patients, showed a downward trajectory of physical 
activity over time, evidenced through a 16% and 
18% decrease in daily steps over 6 months and a 
year, respectively [10]. It is clear from our preliminary 
data, that “shielding” has further exacerbated 
physical activity decline, shown through a 39% 
reduction in daily steps from post-PR to shielding 
(3 months). The deterioration (−1620±1573 steps 
per day) also exceeds that previously exhibited 
over the year following PR of 600–1000 steps 
[11, 12]. Furthermore, there was a 32% decline 
from pre-PR to shielding. This worsening below 
pre-rehabilitation suggests that not only could 
some of the benefits attained during PR be lost, 
but also further deconditioning is likely to have 
occurred, potentially resulting in worsened long-
term disease-related outcomes and an increased 
risk of comorbidities. Additionally, the decline is 
significantly higher than that seen in the general UK 
population (−7.8%) during the lockdown period [13]. 
This is partly due to the total home confinement 
of shielding compared with partial confinement for 
non-vulnerable individuals, as other countries with 
more stringent restrictions had a greater decline. 
However, shielding has probably exacerbated the 
vicious cycle of declining physical activity, leading to 
increased symptoms and further activity avoidance, 
which is already evident in COPD patients.
Physical inactivity and deconditioning can often 
lead to worsening symptoms (breathlessness and 
leg discomfort), and subsequent worsening of 
physical functioning and HRQoL [14]. The data 
collected from this cohort showed a decline in CCQ 
scores from post-PR to shielding which exceeded 
clinically meaningful margins (±0.4 points) 
for both functional (+0.5 points) and mental 
domains (+0.7 points) (figure 2). This indicates 
that shielding caused patients to feel increasingly 
limited when conducting daily physical activities, 
which is accompanied with heightened feelings 
of depression and concerns about breathing. In 
the general population, the strong link between 
social isolation and anxiety, depression and 
cognitive decline is well established [15]. It is 
perhaps surprising that no statistically or clinically 
meaningful changes in anxiety or depression (HADS) 
and health-related quality of life (CAT scores) were 
seen in this follow-up. It is possible that patients 
initially felt safer whilst shielding; however, it will be 
interesting to follow these patients longitudinally 
to observe if any changes ensue as the uncertainty 
of the COVID-19 pandemic continues.
Clinical implications
The findings from this follow-up confirm that 
the shielding period has caused a significant 
deterioration in patients’ physical activity within 
a short time period of 3 months. It is important to 
consider that this data reflects patients who have 
recently undergone PR; therefore, it is likely that 
the effects of shielding are worse for the remaining 
COPD population who have not recently participated 
in PR. Due to the well-established association 
between physical inactivity and adverse clinical 
outcomes, focus on supporting patients to self-
manage their condition and remain physically 
active at home is imperative. This could be done by 
using tools, such as tablet computers, pedometers, 
pulse oximeters and exercise diaries, while providing 
remote specialist support (e.g. over the telephone) 
to increase patient confidence to exercise at home 
independently [16].
The pandemic has increased the urgency of 
developing novel ways of delivering PR programmes 
and supporting patients remotely. Clinicians 
continue to explore alternative modes of remote PR 


























Figure  1 a) Daily steps and b) C-PPAC scores pre-PR, post-PR and during shielding. Data are presented as mean±sd. 
*:  significant difference between time points, p<0.05; #: clinically meaningful difference between time points.
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minimally supervised rehabilitation, internet-based 
programmes, pedometer-based programmes, yoga 
and t’ai chi exercise. Indeed, virtual consultations 
have emerged as a consequence of the pandemic, 
replacing face-to-face consultations. These have 
been found to be largely acceptable by both patients 
and clinicians [17]. In the majority of cases, virtual 
consultations are taking place over the telephone but 
there is also the possibility for video consultations, 
when the patient has access to the internet and 
can use a tablet computer or smart phone. Video 
consultations may be conducted over communication 
platforms (e.g. Microsoft Teams or Zoom) or preferably 
other secure platforms hosted by the National Health 
Authorities (such as “Attend Anywhere” in the UK).
Virtual consultations should aim to provide 
patients with a tailored programme at home 
including: 1) an educational component on 
managing the disease; 2) psychological support; 
3) nutritional support; 4) advice to be physically 
active indoors and outdoors (if in accordance with 
public health guidance); 5) access to resource 
packs for improving well-being; and 6) home 
diaries for patients to record their progress and 
symptoms that can be reviewed regularly by 
healthcare professionals. Where resources are 
limited, patients may be directed to established 
sources such as the British Lung Foundation or 
Lung Foundation Australia with access to specifically 
designed exercise videos, or handbooks for those 
without internet access [18, 19]. Safety guidance 
for remotely supervised interventions provided 
by national respiratory societies [20] should be 
followed closely to ensure patient safety and correct 
prescription of exercise. The preliminary data from 
this follow-up indicates that the instruction to shield 
in vulnerable, clinical populations might have been a 
double-edged sword, and clinicians should be wary 
of long-term detrimental effects when returning to 
patient treatment.
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Figure  2 a) CCQ total score, b) symptom score, c) functional state score and d) mental state score pre-PR, post-PR and 
during shielding. Data are presented as mean±sd. #: clinically meaningful difference between time points.
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